Fonte: Journal of Neuro-Oncology. Unidade: ICB
Assuntos: HISTOLOGIA, RADIOTERAPIA, SISTEMA NERVOSO PERIFÉRICO, CÉLULAS CULTIVADAS DE TUMOR, PROLIFERAÇÃO CELULAR
ABNT
YAMASHITA, Alex Shimura et al. Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors. Journal of Neuro-Oncology, v. 118, n. 1, p. 83-92, 2014Tradução . . Disponível em: https://doi.org/10.1007/s11060-014-1422-5. Acesso em: 22 maio 2024.APA
Yamashita, A. S., Baia, G. S., Ho, J. S. Y., Velarde, E., Wong, J., Gallia, G. L., et al. (2014). Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors. Journal of Neuro-Oncology, 118( 1), 83-92. doi:10.1007/s11060-014-1422-5NLM
Yamashita AS, Baia GS, Ho JSY, Velarde E, Wong J, Gallia GL, Belzberg AJ, Kimura ET, Riggins GJ. Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors [Internet]. Journal of Neuro-Oncology. 2014 ; 118( 1): 83-92.[citado 2024 maio 22 ] Available from: https://doi.org/10.1007/s11060-014-1422-5Vancouver
Yamashita AS, Baia GS, Ho JSY, Velarde E, Wong J, Gallia GL, Belzberg AJ, Kimura ET, Riggins GJ. Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors [Internet]. Journal of Neuro-Oncology. 2014 ; 118( 1): 83-92.[citado 2024 maio 22 ] Available from: https://doi.org/10.1007/s11060-014-1422-5